There are many different types of T–cell lymphomas, and treatment can vary. and long-term survival is common, especially if the lymphoma cells have too much .
Survival rates for non-Hodgkin lymphoma. The overall 5-year relative survival rate for people with NHL is 70%, and the 10-year relative survival rate is 60%. But it's important to keep in mind that survival rates can vary widely for different types and stages of lymphoma.
The 3-year survival rates of low risk,low-intermediate risk,intermediate-high risk, and high risk groups were 60%, 30%, 10%, and 0%, respectively. CONCLUSIONS: Present treatment modalities for T-cell NHL patients, especially the high risk patients, can't achieve satisfactory outcomes.
French and Italian investigators have documented long-term survival rates of approximately 90% for ALCL patients who underwent autologous HSCT in first CR. These results are encouraging, but patients with systemic ALCL (especially ALK-positive) have the best prognosis among those with T–cell NHL subtypes.
T–cell Lymphoma can develop in lymphoid tissues such as the lymph nodes and spleen,. The non-systemic type is called primary cutaneous anaplastic large cell lymphoma, appears only on the skin, and has a good prognosis.. period, it is called a durable remission. rate can be very high and many patients can be cured.